Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
A new SPS elective uses improvisation, behavioral science, and performance practice to help graduate students turn knowledge into presence, adaptability, and real-time professional impact.
Faculty
Project Management Professor Howard N. Apsan reflects on the enduring lessons of 9/11 and the leadership-by-example legacy of the first responders who ran toward danger.
Faculty
Environmental scientists monitor and analyze planetary conditions to develop data-driven solutions to sustainability challenges.
All News
